How Tom voted.

Mobilisation of the European Globalisation Adjustment Fund - EGF/2019/001 BE/Carrefour - Belgium (Motion adopted): 558 For, 63 Against, 43 Abstention, 143 Did not vote (807 Members). Tom Vandenkendelaere: Did not vote.

Opening accession negotiations with North Macedonia and Albania (Motion adopted): 412 For, 136 Against, 30 Abstention, 191 Did not vote (769 Members). Tom Vandenkendelaere: Did not vote.

State of play of the disclosure of income tax information by certain undertakings and branches - public country-by-country reporting (Motion adopted): 572 For, 42 Against, 21 Abstention, 160 Did not vote (795 Members). Tom Vandenkendelaere: Did not vote.

Objection pursuant to Rule 112 : partially granting an authorisation for a use of chromium trioxide (Cromomed S.A. and others) (Motion adopted): 301 For, 295 Against, 45 Abstention, 158 Did not vote (799 Members). Tom Vandenkendelaere: Did not vote.

Uganda, notably the proposed bill to impose capital punishment of homosexual acts (Motion adopted): 521 For, 4 Against, 110 Abstention, 159 Did not vote (794 Members). Tom Vandenkendelaere: Did not vote.

Commission Regulation amending Regulation (EU) No 546/2011 as regards the assessment of the impact of plant protection products on honeybees (Motion adopted): 533 For, 67 Against, 100 Abstention, 115 Did not vote (815 Members). Tom Vandenkendelaere: Did not vote.

Discharge 2017: General budget of the EU - Council and European Council (Motion adopted): 662 For, 24 Against, 9 Abstention, 118 Did not vote (813 Members). Tom Vandenkendelaere: Did not vote.

Discharge 2017: European Asylum Support Office (EASO) (Motion adopted): 694 For, 2 Against, 2 Abstention, 119 Did not vote (817 Members). Tom Vandenkendelaere: Did not vote.

General budget of the European Union for the financial year 2020 - all sections (Motion adopted): 529 For, 130 Against, 43 Abstention, 116 Did not vote (818 Members). Tom Vandenkendelaere: Did not vote.

Employment and social policies of the euro area (Motion adopted): 422 For, 131 Against, 101 Abstention, 138 Did not vote (792 Members). Tom Vandenkendelaere: Did not vote.

Multiannual Financial Framework 2021-2027 and own resources: time to meet citizen’s expectations (Motion adopted): 426 For, 163 Against, 67 Abstention, 134 Did not vote (790 Members). Tom Vandenkendelaere: Did not vote.

Foreign interferences in Member States and European democratic processes (Motion adopted): 469 For, 143 Against, 47 Abstention, 132 Did not vote (791 Members). Tom Vandenkendelaere: Did not vote.

Objection pursuant to Rule 112 : authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 × DAS-40278-9 and genetically modified maize combining two, three or four of the single events MON 89034, 1507, MON 88017, 59122 and DAS-40278-9 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (D062827-03) (Motion adopted): 435 For, 207 Against, 18 Abstention, 130 Did not vote (790 Members). Tom Vandenkendelaere: Did not vote.

Objection pursuant to Rule 112 : renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean A2704-12 (ACS-GMØØ5-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (D062417-04) (Motion adopted): 426 For, 208 Against, 20 Abstention, 132 Did not vote (786 Members). Tom Vandenkendelaere: Did not vote.

Objection pursuant to Rule 112 : the placing on the market of products containing, consisting of or produced from genetically modified maize MZHG0JG (SYN-ØØØJG-2), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (D061869-04) (Motion adopted): 436 For, 208 Against, 16 Abstention, 130 Did not vote (790 Members). Tom Vandenkendelaere: Did not vote.

Objection pursuant to Rule 112: Extension of the approval periods of the active substances amidosulfuron, beta cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (D062951) (Motion adopted): 417 For, 200 Against, 40 Abstention, 135 Did not vote (792 Members). Tom Vandenkendelaere: Did not vote.

Objection pursuant to Rule 112: Extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (D061354) (Motion adopted): 402 For, 222 Against, 39 Abstention, 128 Did not vote (791 Members). Tom Vandenkendelaere: Did not vote.